Recent Quotes (30 days)

You have no recent quotes
chg | %

Promis Neurosciences Inc  

(Public, TSE:PMN)   Watch this stock  
Find more results for TSE:AMF
0.0500
-0.0050 (-9.09%)
May 4 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.05 - 0.05
52 week 0.04 - 0.12
Open 0.05
Vol / Avg. 383,000.00/150,893.00
Mkt cap 8.45M
P/E     -
Div/yield     -
EPS -0.02
Shares 153.70M
Beta -0.96
Inst. own     -
May 24, 2016
Q1 2016 Promis Neurosciences Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 23, 2016
Q4 2015 Promis Neurosciences Inc Earnings Release
  

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -9279.19% -
Operating margin -9212.48% -
EBITD margin - -
Return on average assets -302.86% -
Return on average equity -2794.90% -
CDP Score - -

Address

Suite 200, 1920 Yonge Street
TORONTO, ON M4S 3E2
Canada
+1-416-8476898 (Phone)
+1-416-8476899 (Fax)

Website links

Description

Promis Neurosciences Inc, formerly Amorfix Life Sciences Ltd, is a Canada-based company engaged in developing medicine solutions for the detection and treatment of neurodegenerative diseases, in particular Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). The Company applies its thermodynamic, computational discovery platform, ProMIS and Collective Coordinates, to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins. Using this approach, ProMIS Neurosciences Inc focuses on the development of antibody therapeutics and specific companion diagnostics for Alzheimer's disease and ALS. In addition, the Company owns a portfolio of therapeutic and diagnostic patents relating to misfolded one of three human superoxide dismutases (SOD1) in ALS, and has a preclinical monoclonal antibody therapeutic.

Officers and directors

Eugene Williams Executive Chairman of the Board
Elliot Goldstein M.D. President, Chief Executive Officer, Director
Age: 65
Neil Cashman M.D. Co-Founder, Chief Scientific Officer, Director
Janet Clennett Director - Finance, Acting Chief Financial Officer
Steven S. Plotkin Ph.D. Chief Physics Officer
Robert Gundel Ph.D. Director
Johannes M. Roth Independent Director
Age: 36